Skip to content
Business Times – Lifestyle
Author:
Myosin Therapeutics Inc.
Myosin Therapeutics Invited to Present at BioFuture 2026 in New York City
October 16, 2026
Myosin Therapeutics Selected for 2026-2027 NCI Investor Initiatives Showcase
September 16, 2026
Myosin Therapeutics Initiates Phase 1/2 STAR-GBM Trial of MT-125 Targeting Non-muscle Myosin II in Newly Diagnosed Glioblastoma
May 19, 2026